J Megan Ross1, Jarrod M Ellingson2, Soo Hyun Rhee3, John K Hewitt3, Robin P Corley4, Jeffrey M Lessem4, Naomi P Friedman3. 1. Institute for Behavioral Genetics, University of Colorado Boulder, 447 UCB, Boulder, CO, 80309, United States. Electronic address: Jessica.M.Ross@Colorado.edu. 2. Department of Psychology and Neuroscience, University of Colorado Boulder, United States; Department of Psychiatry, University of Colorado School of Medicine, United States. 3. Institute for Behavioral Genetics, University of Colorado Boulder, 447 UCB, Boulder, CO, 80309, United States; Department of Psychology and Neuroscience, University of Colorado Boulder, United States. 4. Institute for Behavioral Genetics, University of Colorado Boulder, 447 UCB, Boulder, CO, 80309, United States.
Abstract
BACKGROUND: It is unclear whether cannabis use causes cognitive decline; several studies show an association between cannabis use and cognitive decline, but quasi-experimental twin studies have found little support for a causal effect. Here, we evaluate the association of cannabis use with general cognitive ability and executive functions (EFs) while controlling for genetic and shared environmental confounds in a longitudinal twin study. METHODS: We first examined the phenotypic associations between cannabis initiation, frequency, and use disorder with cognitive abilities, while also controlling for pre-use general cognitive ability and other substance involvement. We tested the concurrent association between the cannabis use variables and cognitive abilities in late adolescence and young adulthood and the longitudinal association between cannabis use variables during adolescence and young adulthood cognitive abilities. Next, we used multilevel models to test whether these relations reflect between- and/or within-twin pair associations. RESULTS: Phenotypically, cannabis use was related to poorer cognitive functioning, although most associations were negligible after accounting for other substance use. Nevertheless, there were few significant within-family twin-specific associations, except that age 17 cannabis frequency was associated with worse age 23 Common EF and general cognitive ability. CONCLUSIONS: We found little support for a potential causal effect of cannabis use on cognition, consistent with previous twin studies. Results suggest that cannabis use may not cause decline in cognitive ability among a normative sample of cannabis users.
BACKGROUND: It is unclear whether cannabis use causes cognitive decline; several studies show an association between cannabis use and cognitive decline, but quasi-experimental twin studies have found little support for a causal effect. Here, we evaluate the association of cannabis use with general cognitive ability and executive functions (EFs) while controlling for genetic and shared environmental confounds in a longitudinal twin study. METHODS: We first examined the phenotypic associations between cannabis initiation, frequency, and use disorder with cognitive abilities, while also controlling for pre-use general cognitive ability and other substance involvement. We tested the concurrent association between the cannabis use variables and cognitive abilities in late adolescence and young adulthood and the longitudinal association between cannabis use variables during adolescence and young adulthood cognitive abilities. Next, we used multilevel models to test whether these relations reflect between- and/or within-twin pair associations. RESULTS: Phenotypically, cannabis use was related to poorer cognitive functioning, although most associations were negligible after accounting for other substance use. Nevertheless, there were few significant within-family twin-specific associations, except that age 17 cannabis frequency was associated with worse age 23 Common EF and general cognitive ability. CONCLUSIONS: We found little support for a potential causal effect of cannabis use on cognition, consistent with previous twin studies. Results suggest that cannabis use may not cause decline in cognitive ability among a normative sample of cannabis users.
Authors: L John Horwood; David M Fergusson; Mohammad R Hayatbakhsh; Jake M Najman; Carolyn Coffey; George C Patton; Edmund Silins; Delyse M Hutchinson Journal: Drug Alcohol Depend Date: 2010-04-24 Impact factor: 4.492
Authors: Nicholas J Jackson; Joshua D Isen; Rubin Khoddam; Daniel Irons; Catherine Tuvblad; William G Iacono; Matt McGue; Adrian Raine; Laura A Baker Journal: Proc Natl Acad Sci U S A Date: 2016-01-19 Impact factor: 11.205
Authors: Naomi P Friedman; Akira Miyake; Lee J Altamirano; Robin P Corley; Susan E Young; Sally Ann Rhea; John K Hewitt Journal: Dev Psychol Date: 2016-02
Authors: Ty A Ridenour; Ralph E Tarter; Maureen Reynolds; Ada Mezzich; Levent Kirisci; Michael Vanyukov Journal: Drug Alcohol Depend Date: 2009-03-05 Impact factor: 4.492
Authors: Jonathan D Schaefer; Nayla R Hamdi; Stephen M Malone; Scott Vrieze; Sylia Wilson; Matt McGue; William G Iacono Journal: Proc Natl Acad Sci U S A Date: 2021-04-06 Impact factor: 11.205
Authors: Jarrod M Ellingson; J Megan Ross; Evan Winiger; Michael C Stallings; Robin P Corley; Naomi P Friedman; John K Hewitt; Susan F Tapert; Sandra A Brown; Tamara L Wall; Christian J Hopfer Journal: Addiction Date: 2020-09-03 Impact factor: 6.526
Authors: Jarrod M Ellingson; Jesse D Hinckley; J Megan Ross; Joseph P Schacht; L Cinnamon Bidwell; Angela D Bryan; Christian J Hopfer; Paula Riggs; Kent E Hutchison Journal: Curr Behav Neurosci Rep Date: 2021-11-15
Authors: T Jordan Walter; Nina Pocuca; Jared W Young; Mark A Geyer; Arpi Minassian; William Perry Journal: Psychiatry Res Date: 2020-12-29 Impact factor: 3.222
Authors: J Megan Ross; Jarrod M Ellingson; Maia J Frieser; Robin C Corley; Christian J Hopfer; Michael C Stallings; Sally J Wadsworth; Chandra A Reynolds; John K Hewitt Journal: Drug Alcohol Depend Date: 2021-11-27 Impact factor: 4.492